Vault-13

BIOPHARMA CREDIT PLC BOPCF

COM · Closed-End Fund · CUSIP G12808104

1 institutional holders +0 vs Q1 2023
1,332,3541.3m shares reported held*
$1.2mreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $517.4k (-578.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.90.

Trends to Q2 2023

Institutional holders

Managers reporting a position, each quarter

001Q3 22: 1Q4 22: 1Q1 23: 1Q2 23: 11Q3 22Q4 22Q1 23Q2 23
Numbers
QuarterHolders
Q3 20221
Q4 20221
Q1 20231
Q2 20231

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q4 22: 1 bought or addedQ4 22: 0 cut or sold outQ4 22Q1 23: 1 bought or addedQ1 23: 0 cut or sold outQ1 23Q2 23: 0 bought or addedQ2 23: 1 cut or sold outQ2 23
Numbers
QuarterBought or addedCut or sold out
Q4 202210
Q1 202310
Q2 202301

Biggest buyers

None

Biggest sellers

Aubrey Capital Management Ltd Reduced -578,049-578.0k

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Aubrey Capital Management Ltd 0.78% of their portfolio EDINBURGH, X0 1,332,3541.3m $1.2m $1.2m 0.78% Reduced -578.0k -578,049